MONEY

Capricor Therapeutics shares rise as FDA decision nears

ByFinance Desk

Nov 11, 2026 , , , , , , , ,

Capricor Therapeutics shares rise as FDA decision nears

Source link

By Finance Desk

Related Post

MONEY

Gen Restaurant Group targets $40M CPG revenue run rate by end of 2027 while planning ~75% overhead cut (NASDAQ:GENK)

Nov 11, 2026 Finance Desk
MONEY

NextNav highlights single-digit-meter positioning in Santa Clara while ending Q3 2026 with about $290M in liquidity (NASDAQ:NN)

Nov 11, 2026 Finance Desk
MONEY

Mobile Infrastructure reiterates 2026 guidance with revenue at low end of $35M-$38M range (NASDAQ:BEEP)

Nov 10, 2026 Finance Desk

Leave a Reply

You missed

SHOW BIZ

Thomas Markle Sr. cut off his ankle monitor following child porn arrest

Nov 11, 2026 News Desk
MONEY

Capricor Therapeutics shares rise as FDA decision nears

Nov 11, 2026 Finance Desk
POLITICS

L.A. County restraining order system to undergo sweeping reforms

Nov 11, 2026 Politics Desk
SPORT

WTA Finals: Linda Noskova beats Coco Gauff to reach semi-finals, Jessica Pegula wins

Nov 11, 2026 Sports Desk

Discover more from Occasional Digest

Subscribe now to keep reading and get access to the full archive.

Continue reading